Sight Sciences Inc
Research Sight Sciences Inc (SGHT) on Bullrun: market cap USD 455.24M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSGHT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 455.24M
- Financial periodQ2 2026
- RevenueUSD 23.39M
- Net income-USD 4.45M
- Free cash flow-USD 5.68M
- Gross margin91.4%
Valuation Snapshot
latest market cap is USD 455.24M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 77.36M | -USD 38.43M | -USD 29.92M | 86.2% | -0.74 | USD 91.97M | USD 40.30M | USD 63.94M |
| FY2024 | USD 79.87M | -USD 51.51M | -USD 22.74M | 85.5% | -1.03 | USD 120.36M | USD 39.36M | USD 87.52M |
| FY2023 | USD 81.06M | -USD 55.55M | -USD 47.98M | 85.3% | -1.14 | USD 138.13M | USD 33.93M | USD 120.22M |
| FY2022 | USD 71.33M | -USD 86.24M | -USD 76.94M | 82.7% | -1.8 | USD 185.00M | USD 33.31M | USD 160.08M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 455.24M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 424.21M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 185.41M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 251.55M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 587.93M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 834.66M | n/a | n/a | n/a |
About Sight Sciences Inc
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sight Sciences Inc's market cap?
Sight Sciences Inc's market capitalization is USD 455.24M.
What does Sight Sciences Inc do?
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye.